Expert Advice For Previously Heavy Zantac Users

Now that the FDA has banned the sale of Zantac and recommended users stop taking the medication, millions of Americans are looking for heartburn and acid-reflux advice

Thursday, April 16, 2020 - At the heart of the issue regarding Zantac cancer is an online drug testing pharmacy Valisure. In October 2019, the company testing found alarmingly higher than acceptable levels of N-Nitrosodimethylamine (NDMA), a known carcinogen, in Zantac tablets. NDMA is a highly naturally occurring chemical that is carcinogenic and used by researchers to induce tumors in laboratory animals. Levels of NDMA have been found to increase when Zantac and other drugs containing the carcinogen are stored at higher than normal room temperatures and also when interacting with nitrites in processed meats, ironically one of the foods that cause acid reflux and heartburn. Zantac Antacid cancer lawsuit attorneys have vast experience litigating against pharmaceutical companies and offer a free consultation with no obligation to file a claim.

Despite no cases of human cancer being definitively linked to taking Zantac, the US Food and Drug Administration (FDA) has banned the sale of the drug in the United States and insists that consumers stop using the drug and dispose of any unused portions. Prevention.com a leading provider of trustworthy health information, has weighed in on the issue of Zantac cancer, advising their 5 million monthly readers to get all of the facts so they can make an informed decision. After reviewing a recent article on Zantac, the world's most popular and best-selling anti-heartburn and acid-reflux medication the publication offers solutions other than stopping taking antacid medications cold-turkey. Each Zantac users should consult with their physician for guidance on alternative medications and lifestyle changes that they may need to implement.

Zantac users should consider other medications on the market that can produce similar heartburn and acid reflux relief. Those quitting Zantac may wish to consider switching to alternative medications that do not contain NDMA, the chemical that causes cancer in humans. Prevention lists other popular antacid brands such as famotidine (Pepcid), cimetidine (Tagamet), esomeprazole (Nexium), lansoprazole (Prevacid), and omeprazole (Prilosec) as being FDA recommended because of their lack of NDMA.

Dr. Robert Weber, Pharm.D., pharmacy administrator at The Ohio State University Wexner Medical Center is concerned that abruptly stopping taking Zantac without first implementing healthy dietary changes could cause a painful and dangerous spike in stomach acid levels. Prevention interviewed Dr. Weber for his thoughts on what he is advising previously heavy Zantac users to do. Like any responsible physician, Dr. Weber recommends basic diet improvements such as quitting smoking, drinking caffeinated beverages like coffee, tea, and caffeinated soft drinks, and drinking alcohol as a preventative measure to fight the onset of acid indigestion. Other foods changes Dr. Weber recommends are, according to Prevention, "Other foods include alcohol, particularly red wine, black pepper, garlic, raw onions, and spicy foods and hot sauce," he says. Other foods like chocolate and citrus fruits and products, such as lemons, oranges, OJ, and tomatoes can cause issues, too, he says."

According to their website: "For 70 years, the Prevention brand has been a leading provider of trustworthy health information, empowering readers with practical strategies to improve their physical, mental, and emotional well-being."

More Recent Heartburn MedicineLawsuit News:

• Zantac Cancer Trials Are In Discovery To Begin In October 2022 | 7/19/2022
• Zantac Cancer Lawsuits Could Hinge On The Validity of Ranitidine Testing Methods | 7/11/2022
• Zantac Cancer Bellwether Trials In California Could Set The Stage For A Global Settlement Offer | 7/5/2022
• The FDA Recommended Protein Pump Inhibitor Drugs Like Prilosec And Nexium That May Damage Health More Than Zantac | 6/23/2022
• Truck Drivers, Firefighters, and Police Officers May Have Taken More Zantac Than People In Other Occupations | 6/20/2022
• Scientists Are Expected To Confirm That Ranidine Causes Gastrointestinal Cancer With Slam Dunk Testimony | 6/9/2022
• Scientific Hearings Will Start This September To Interview Zantac Cancer Expert Witnesses | 5/19/2022
• A Whistleblower Scientist Working For A Chinese Company Thinks NDMA Contamination Started In China | 5/12/2022
• Valisure's String Of Stunning Success Casts Doubt On The FDAs Ability To Police The Health Care Market | 5/2/2022
• Zantac Testing Accusations Heat Up With FDA Investigation Of Online Prescription Drug Testing Lab | 4/25/2022
• Study Finds Ranitidine Degrades Into 10,000 Nanograms of NDMA When Introduced To Simulated Stomach Conditions | 4/6/2022
• Potential Zantac Expert Witnesses Are Being Questioned By Zantac Defense Attorneys | 3/31/2022
• The FDA Requires That Drug Companies Regularly Test Ranitidine And Other Drug For NDMA | 3/24/2022
• Update: Where The Zantac Cancer Multidistrict Litigation (MDL) Stands Today | 3/12/2022
• Zantac Cancer Plaintiffs Look To The First Trial In October In Alameda California | 3/11/2022
• Zantac Cancer Plaintiffs Have Until June 30 To Finalize Their Claim | 3/7/2022
• Zantac Bellwether Trials May Focus On Ranitidine Testing Methods That Could Cause NDMA To Accelerate | 3/1/2022
• Valisure LLC's Motivations And Ranitidine Testing Methods May Not Be Scrutinized Before Trial | 2/24/2022
• Zantac Lawsuits May Go To Trial In California In October Of This Year | 2/18/2022
• Sanofi's History Of Reprehensible Corporate Behavior May Bolster Zantac Cancer Lawsuits | 2/10/2022

Lawyers for Zantac Heartburn Medicine Lawsuits

OnderLaw, LLC is a St. Louis personal injury law firm handling serious injury and death claims across the country. Its mission is the pursuit of justice, no matter how complex the case or strenuous the effort. The Onder Law Firm has represented clients throughout the United States in pharmaceutical and medical device litigation such as Pradaxa, Lexapro and Yasmin/Yaz, where the firm's attorneys held significant leadership roles in the litigation, as well as Actos, DePuy, Risperdal and others. The Onder Law Firm has won more than $300 million in four talcum powder ovarian cancer lawsuits in St. Louis. Law firms throughout the nation often seek its experience and expertise on complex litigation.